CAPZA1 overexpression was associated with well differentiated histology, smaller tumor size, lower T stage, absence of lymph node metastasis, lower TNM stage, lower recurrence rate and longer survival time, compared to CAPZA1 underexpression. The gene discussed is CAPZA1; the disease is metastatic malignant neoplasm in the lymph nodes.